192 related articles for article (PubMed ID: 31900718)
41. NLRC5 regulates TGF-β1-induced proliferation and activation of hepatic stellate cells during hepatic fibrosis.
Xu T; Ni MM; Xing-Li ; Li XF; Meng XM; Huang C; Li J
Int J Biochem Cell Biol; 2016 Jan; 70():92-104. PubMed ID: 26592197
[TBL] [Abstract][Full Text] [Related]
42. Astragaloside prevents BDL-induced liver fibrosis through inhibition of notch signaling activation.
Yongping M; Zhang X; Xuewei L; Fan W; Chen J; Zhang H; Chen G; Liu C; Liu P
J Ethnopharmacol; 2015 Jul; 169():200-9. PubMed ID: 25917841
[TBL] [Abstract][Full Text] [Related]
43. Inhibition of extracellular signal-regulated kinase 1 by adenovirus mediated small interfering RNA attenuates hepatic fibrosis in rats.
Zhong W; Shen WF; Ning BF; Hu PF; Lin Y; Yue HY; Yin C; Hou JL; Chen YX; Zhang JP; Zhang X; Xie WF
Hepatology; 2009 Nov; 50(5):1524-36. PubMed ID: 19787807
[TBL] [Abstract][Full Text] [Related]
44. Secondary biliary cirrhosis in the rat is prevented by decreasing NF-κB nuclear translocation and TGF-β expression using allopurinol, an inhibitor of xanthine oxidase.
Aldaba-Muruato LR; Moreno MG; Hernández-Mercado E; Shibayama M; Muriel P
Can J Physiol Pharmacol; 2012 Nov; 90(11):1469-78. PubMed ID: 23181275
[TBL] [Abstract][Full Text] [Related]
45. Loss of cellular FLICE-inhibitory protein promotes acute cholestatic liver injury and inflammation from bile duct ligation.
Gehrke N; Nagel M; Straub BK; Wörns MA; Schuchmann M; Galle PR; Schattenberg JM
Am J Physiol Gastrointest Liver Physiol; 2018 Mar; 314(3):G319-G333. PubMed ID: 29191940
[TBL] [Abstract][Full Text] [Related]
46. Preventive and therapeutic effects of angiotensin II type 1 receptor blocker on hepatic fibrosis induced by bile duct ligation in rats.
Ueki M; Koda M; Yamamoto S; Matsunaga Y; Murawaki Y
J Gastroenterol; 2006 Oct; 41(10):996-1004. PubMed ID: 17096069
[TBL] [Abstract][Full Text] [Related]
47. Yinchenhao Decoction Alleviates Liver Fibrosis by Regulating Bile Acid Metabolism and TGF-β/Smad/ERK Signalling Pathway.
Cai FF; Wu R; Song YN; Xiong AZ; Chen XL; Yang MD; Yang L; Hu Y; Sun MY; Su SB
Sci Rep; 2018 Oct; 8(1):15367. PubMed ID: 30337590
[TBL] [Abstract][Full Text] [Related]
48. Protective effect of bicyclol against bile duct ligation-induced hepatic fibrosis in rats.
Zhen YZ; Li NR; He HW; Zhao SS; Zhang GL; Hao XF; Shao RG
World J Gastroenterol; 2015 Jun; 21(23):7155-64. PubMed ID: 26109801
[TBL] [Abstract][Full Text] [Related]
49. Astragaloside IV alleviates silica‑induced pulmonary fibrosis via inactivation of the TGF‑β1/Smad2/3 signaling pathway.
Li N; Wu K; Feng F; Wang L; Zhou X; Wang W
Int J Mol Med; 2021 Mar; 47(3):. PubMed ID: 33448318
[TBL] [Abstract][Full Text] [Related]
50. Imidazoline I2 receptor inhibitor idazoxan regulates the progression of hepatic fibrosis via Akt-Nrf2-Smad2/3 signaling pathway.
Xuanfei L; Hao C; Zhujun Y; Yanming L; Jianping G
Oncotarget; 2017 Mar; 8(13):21015-21030. PubMed ID: 28423499
[TBL] [Abstract][Full Text] [Related]
51. MicroRNA-34a-5p inhibits liver fibrosis by regulating TGF-β1/Smad3 pathway in hepatic stellate cells.
Feili X; Wu S; Ye W; Tu J; Lou L
Cell Biol Int; 2018 Sep; 42(10):1370-1376. PubMed ID: 29957876
[TBL] [Abstract][Full Text] [Related]
52. TGF-β Type I Receptor Kinase Inhibitor EW-7197 Suppresses Cholestatic Liver Fibrosis by Inhibiting HIF1α-Induced Epithelial Mesenchymal Transition.
Kim MJ; Park SA; Kim CH; Park SY; Kim JS; Kim DK; Nam JS; Sheen YY
Cell Physiol Biochem; 2016; 38(2):571-88. PubMed ID: 26845171
[TBL] [Abstract][Full Text] [Related]
53. Morin attenuates diethylnitrosamine-induced rat liver fibrosis and hepatic stellate cell activation by co-ordinated regulation of Hippo/Yap and TGF-β1/Smad signaling.
Perumal N; Perumal M; Halagowder D; Sivasithamparam N
Biochimie; 2017 Sep; 140():10-19. PubMed ID: 28552397
[TBL] [Abstract][Full Text] [Related]
54. Ampelopsin attenuates carbon tetrachloride-induced mouse liver fibrosis and hepatic stellate cell activation associated with the SIRT1/TGF-β1/Smad3 and autophagy pathway.
Ma JQ; Sun YZ; Ming QL; Tian ZK; Yang HX; Liu CM
Int Immunopharmacol; 2019 Dec; 77():105984. PubMed ID: 31677501
[TBL] [Abstract][Full Text] [Related]
55. Astragaloside IV attenuates myocardial fibrosis by inhibiting TGF-β1 signaling in coxsackievirus B3-induced cardiomyopathy.
Chen P; Xie Y; Shen E; Li GG; Yu Y; Zhang CB; Yang Y; Zou Y; Ge J; Chen R; Chen H
Eur J Pharmacol; 2011 May; 658(2-3):168-74. PubMed ID: 21371462
[TBL] [Abstract][Full Text] [Related]
56. Astragaloside IV suppresses migration and invasion of TGF-β
Li L; Wang Q; He Y; Sun L; Yang Y; Pang X
Naunyn Schmiedebergs Arch Pharmacol; 2022 Apr; 395(4):397-405. PubMed ID: 35092472
[TBL] [Abstract][Full Text] [Related]
57. Resveratrol suppresses cholestasis-induced liver injury and fibrosis in rats associated with the inhibition of TGFβ1-Smad3-miR21 axis and profibrogenic and hepatic injury biomarkers.
ShamsEldeen AM; Al-Ani B; Ebrahim HA; Rashed L; Badr AM; Attia A; Farag AM; Kamar SS; Haidara MA; Al Humayed S; Ali Eshra M
Clin Exp Pharmacol Physiol; 2021 Oct; 48(10):1402-1411. PubMed ID: 34157155
[TBL] [Abstract][Full Text] [Related]
58. Magnesium isoglycyrrhizinate ameliorates liver fibrosis and hepatic stellate cell activation by regulating ferroptosis signaling pathway.
Sui M; Jiang X; Chen J; Yang H; Zhu Y
Biomed Pharmacother; 2018 Oct; 106():125-133. PubMed ID: 29957462
[TBL] [Abstract][Full Text] [Related]
59. Protective Effects of Astragaloside IV Combined with Budesonide in Bronchitis in Rats by Regulation of Nrf2/Keap1 Pathway.
Zhang Z; Cheng X; Ge D; Wang S; Qi B
Med Sci Monit; 2018 Nov; 24():8481-8488. PubMed ID: 30471087
[TBL] [Abstract][Full Text] [Related]
60. Assessment of the possible roles of SB-269970 versus ketanserin on carbon tetrachloride-induced liver fibrosis in rats: Oxidative stress/TGF-β
Atallah MAA; Elaidy SM; Tawfik MK
Pharmacol Rep; 2018 Jun; 70(3):509-518. PubMed ID: 29660654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
